<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02098265</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0469</org_study_id>
    <secondary_id>A539300</secondary_id>
    <secondary_id>SMPH/RADIOLOGY</secondary_id>
    <secondary_id>15GRNT25780033</secondary_id>
    <secondary_id>August 10, 2019</secondary_id>
    <nct_id>NCT02098265</nct_id>
  </id_info>
  <brief_title>A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device</brief_title>
  <official_title>A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to determine if two non-invasive brain stimulation&#xD;
      techniques, muscle stimulation of the arm and neuro-stimulation through the tongue, can&#xD;
      increase the extent of stroke recovery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to determine if functional muscle stimulation, in addition to&#xD;
      non-invasive neurostimulation through the tongue (TDU), directed by electroencephalogram&#xD;
      (EEG) output, can increase the extent of stroke recovery on behavioral measures and induce&#xD;
      brain plasticity as measured by functional magnetic resonance imaging (fMRI).&#xD;
&#xD;
      Adult stroke patients with upper extremity motor impairments (henceforth &quot;experimental&#xD;
      group&quot;), healthy controls, and participants with risk factors for stroke, without upper&#xD;
      extremity impairment (allowing them to serve as controls for patients with upper extremity&#xD;
      impairments (henceforth &quot;control group&quot;)), will be recruited in this study. Half of the&#xD;
      participants in the experimental group will be randomly assigned to the EEG-BCI&#xD;
      (brain-computer interface) training (&quot;closed-loop&quot;) group and will receive training on the&#xD;
      BCI task along with muscle and tongue stimulation. The other half of the participants in the&#xD;
      experimental group receiving traditional rehab will not receive any kind of FES or tongue&#xD;
      stimulation for the first 8-10 weeks of study period and then will start receiving&#xD;
      BCI-FES-tongue stimulation rehab therapy.&#xD;
&#xD;
      All participants without UE impairment in Control group 1 will receive 4-6 (minimum 4, up to&#xD;
      a maximum of 6) sessions of training on the BCI system and pre- and post MRI and 2 behavioral&#xD;
      testing sessions.&#xD;
&#xD;
      Addition of a Control group 2 is consistent with the AHA grants - Twenty four ischemic stroke&#xD;
      patients with moderate upper extremity (dominant right hand affected) impairment (score of 1&#xD;
      or 2 on the motor sub-component of the NIH stroke scale (NIHSS) and ARAT score 20-45); no&#xD;
      upper extremity injury or conditions that limited use prior to the stroke; and pre-stroke&#xD;
      independence with a Modified Rankin Score of 0 or 1), will be recruited in this arm. All&#xD;
      participants in this group will receive MR sessions and behavioral testing similar to the&#xD;
      Experimental group.&#xD;
&#xD;
      Addition of an Experimental group receiving EEG-BCI-bilateral FES intervention using the&#xD;
      recoveriX system: recoveriX is a brain driven rehabilitation system for stroke patients that&#xD;
      pairs mental activities with motor functions. Through the EEG-based recoveriX BCI system, the&#xD;
      brain receives visual and tactile feedback in real-time, making rehabilitation more&#xD;
      effective. A stroke patient imagines a hand movement while receiving visual feedback through&#xD;
      a virtual avatar, and tactile feedback through electrical muscle stimulation paired to the&#xD;
      patient's imagined movement, with the aim that these patients might regain the volitional&#xD;
      ability to grasp following therapy. Unlike the current EEG-BCI-FES intervention that involves&#xD;
      stimulation of only the impaired arm, with recoveriX, both arms are simultaneously stimulated&#xD;
      during the course of the intervention.&#xD;
&#xD;
      Specific Aims&#xD;
&#xD;
      To determine if functional muscle stimulation of the arms, in addition to non-invasive&#xD;
      neurostimulation through the tongue (TDU), directed by electroencephalogram (EEG) output, can&#xD;
      increase the extent of stroke recovery as measured by behavioral measures and induce brain&#xD;
      plasticity as measured by functional magnetic resonance imaging (fMRI).&#xD;
&#xD;
      Primary objective&#xD;
&#xD;
        -  To examine the effect of EEG guided functional muscle stimulation on improvement in&#xD;
           upper extremity function&#xD;
&#xD;
      Secondary objective&#xD;
&#xD;
        -  To examine plasticity changes as measured by EEG/fMRI measures before and after EEG&#xD;
           guided functional muscle stimulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2010</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Action Research Arm Test Scores</measure>
    <time_frame>4 months</time_frame>
    <description>The Action Research Arm Test (ARAT) is designed for evaluation of upper extremity function. This test consists of sections for Grasp, Grip, Pinch and Gross Movements and comprise a total of 19 tests. Each test is scored 0-3 where 0 is 'no movement' and 3 is 'the movement is performed normally'. Each section is scored separately and the scores added for a total possible range of scores from 0-57 where the higher the score, the complete and efficient the movement. ARAT will be assessed at baseline and end of study (approximately 4 months)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Electroencephalogram (EEG) Response Strength</measure>
    <time_frame>4 months</time_frame>
    <description>The change in the strength of the EEG response before and after functional stimulation during left arm imagery with respect to right arm imagery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signal change in functional MRI</measure>
    <time_frame>4 months</time_frame>
    <description>To compare the percent signal change in the functional MRI activations before and after functional stimulation.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Experimental Group - Immediate BCI Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG - BCI training (closed loop)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Group - Delayed BCI Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Scanned and tested 4 times over a 10-week period before EEG-BCI training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Group - RecoveriX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recruited from participants who have completed the study intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>48 stroke patients, 48 participants with risk factors for stroke, 48 healthy controls receiving 4-6 training sessions on the EEG-BCI, pre- and post- behavioral testing, and MRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>24 Stroke Patients with UE impairment receiving standard FES only therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Functional Electric Stimulation (FES)</intervention_name>
    <description>FES uses low energy electrical pulses to artificially generate body movements in individuals with muscle paralysis. FES can be used to generate muscle contraction in otherwise paralyzed limbs to restore function.</description>
    <arm_group_label>Control Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Assessments</intervention_name>
    <description>These assessments will include measures of upper extremity motor assessments, standard stroke scales, and measures of activities of daily living.</description>
    <arm_group_label>Control Group 1</arm_group_label>
    <arm_group_label>Experimental Group - Delayed BCI Therapy</arm_group_label>
    <arm_group_label>Experimental Group - Immediate BCI Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>A functional magnetic resonance image will be collected.</description>
    <arm_group_label>Control Group 1</arm_group_label>
    <arm_group_label>Experimental Group - Delayed BCI Therapy</arm_group_label>
    <arm_group_label>Experimental Group - Immediate BCI Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EEG</intervention_name>
    <description>EEG electrodes will be attached to the participant's scalp using a standard, commercially available electrode cap. Proper electrode placement is made according to the international 10-20 system, ensuring complete electrode coverage over sensorimotor cortex.</description>
    <arm_group_label>Control Group 1</arm_group_label>
    <arm_group_label>Experimental Group - Delayed BCI Therapy</arm_group_label>
    <arm_group_label>Experimental Group - Immediate BCI Therapy</arm_group_label>
    <other_name>Electroencephalography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RecoveriX</intervention_name>
    <description>RecoveriX is a brain driven rehabilitation system for stroke patients that pairs mental activities with motor functions.</description>
    <arm_group_label>Experimental Group - RecoveriX</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Delay</intervention_name>
    <description>10 week delay before intervention</description>
    <arm_group_label>Experimental Group - Delayed BCI Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BCI-FES</intervention_name>
    <arm_group_label>Control Group 1</arm_group_label>
    <arm_group_label>Experimental Group - Delayed BCI Therapy</arm_group_label>
    <arm_group_label>Experimental Group - Immediate BCI Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Experimental Group):&#xD;
&#xD;
          -  Stroke patients with persistent upper extremity (UE) deficits&#xD;
&#xD;
        Inclusion Criteria (Control Group 1)&#xD;
&#xD;
          -  Stroke patients without UE impairments&#xD;
&#xD;
          -  Participants with risk factors for stroke&#xD;
&#xD;
          -  healthy controls&#xD;
&#xD;
               -  No known neurologic, psychiatric or developmental disability&#xD;
&#xD;
        Inclusion Criteria (Control Group 2)&#xD;
&#xD;
          -  Stroke patients with persistent upper extremity (UE) deficits&#xD;
&#xD;
          -  Moderate upper extremity (dominant right hand affected) impairment (score of 1 or 2 on&#xD;
             the motor sub-component of the NIH stroke scale (NIHSS) and ARAT score 20-45)&#xD;
&#xD;
          -  No upper extremity injury or conditions that limited use prior to the stroke&#xD;
&#xD;
          -  Pre-stroke independence with a Modified Rankin Score of 0 or 1, for the standard FES&#xD;
             only intervention.&#xD;
&#xD;
        Exclusion Criteria (for all participants):&#xD;
&#xD;
          -  Allergic to electrode gel, surgical tape and metals&#xD;
&#xD;
          -  Participants under treatment for infectious diseases or having apparent oral lesions&#xD;
             or inflammation will be excluded from the study&#xD;
&#xD;
          -  Women who are pregnant or may become pregnant during the course of the study will be&#xD;
             excluded&#xD;
&#xD;
          -  Participants with contraindications for MRI will be offered the opportunity to&#xD;
             participate in the interventions study only (e.g. EEG-BCI-FES and behavioral testing)&#xD;
&#xD;
        Exclusion Criteria (for healthy controls)&#xD;
&#xD;
          -  Contraindications for MRI&#xD;
&#xD;
          -  Allergic to electrode gel, surgical tape, and metals.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivek Prabhakaran, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gemma Gliori, MS</last_name>
    <phone>608-262-7269</phone>
    <email>ggliori@uwhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suzanne Hanson, BS</last_name>
    <phone>608-263-7421</phone>
    <email>shanson@uwhealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Giles, BS</last_name>
      <phone>608-265-8057</phone>
      <email>mpgilles@wisc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Veena Nair, PhD</last_name>
      <phone>608-265-5269</phone>
      <email>vnair@uwhealth.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025476/</url>
    <description>Publication resulting from this work.</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/26157378</url>
    <description>Publication resulting from this work.</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410488/</url>
    <description>Publication resulting from this work.</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/25120466</url>
    <description>Publication resulting from this work.</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067954/</url>
    <description>Publication resulting from this work.</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 6, 2014</study_first_submitted>
  <study_first_submitted_qc>March 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2014</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aneurysm</keyword>
  <keyword>transient ischemic attack</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

